ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4648
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,176.62
0.26%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Bio Path Holdings Inc (BPTH)

  7. Bio Path Holdings Inc (BPTH) Noticias

BPTH

Bio Path (BPTH)

Bio Path Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:BPTH
FechaHoraFuenteTítuloSímboloCompañía
14/06/202416:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
14/06/202406:00GlobeNewswire Inc.Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association CongressNASDAQ:BPTHBio Path Holdings Inc
11/06/202416:30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BPTHBio Path Holdings Inc
05/06/202416:46GlobeNewswire Inc.Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
04/06/202407:00GlobeNewswire Inc.Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
03/06/202406:00GlobeNewswire Inc.Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BPTHBio Path Holdings Inc
24/05/202406:00GlobeNewswire Inc.Bio-Path Holdings to Present Data at 2024 European Hematology Association CongressNASDAQ:BPTHBio Path Holdings Inc
23/05/202416:00GlobeNewswire Inc.Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BPTHBio Path Holdings Inc
15/05/202406:50IH Market NewsU.S. Index Futures Flat Ahead of April CPI Data Release, Oil Prices DropNASDAQ:BPTHBio Path Holdings Inc
15/05/202406:00GlobeNewswire Inc.Bio-Path Holdings Reports First Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
14/05/202415:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BPTHBio Path Holdings Inc
08/05/202406:00GlobeNewswire Inc.Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024NASDAQ:BPTHBio Path Holdings Inc
19/04/202411:14GlobeNewswire Inc.Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
18/04/202412:57GlobeNewswire Inc.Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
18/04/202406:00GlobeNewswire Inc.Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) PatientsNASDAQ:BPTHBio Path Holdings Inc
15/04/202406:00GlobeNewswire Inc.Bio-Path Holdings Expands Global Patent PortfolioNASDAQ:BPTHBio Path Holdings Inc
02/04/202406:00GlobeNewswire Inc.Bio-Path Holdings Provides 2024 Clinical and Operational UpdateNASDAQ:BPTHBio Path Holdings Inc
08/03/202416:11Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BPTHBio Path Holdings Inc
08/03/202406:00GlobeNewswire Inc.Bio-Path Holdings Reports Full Year 2023 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
08/03/202405:22IH Market NewsU.S. Index Futures Fluctuate Ahead of Key Jobs Report; Oil Prices DipNASDAQ:BPTHBio Path Holdings Inc
07/03/202415:21Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BPTHBio Path Holdings Inc
01/03/202406:00GlobeNewswire Inc.Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024NASDAQ:BPTHBio Path Holdings Inc
29/02/202405:00Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BPTHBio Path Holdings Inc
21/02/202406:00GlobeNewswire Inc.Bio-Path Holdings Announces 1-for-20 Reverse Stock SplitNASDAQ:BPTHBio Path Holdings Inc
02/02/202415:39Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BPTHBio Path Holdings Inc
23/01/202415:51Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BPTHBio Path Holdings Inc
17/01/202415:52Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BPTHBio Path Holdings Inc
10/01/202406:00GlobeNewswire Inc.Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia PatientsNASDAQ:BPTHBio Path Holdings Inc
04/01/202416:18Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BPTHBio Path Holdings Inc
22/12/202315:06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BPTHBio Path Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:BPTH

Su Consulta Reciente

NYSE
NKE
Nike
NYSE
KO
Coca Cola
FX
EURMXN
Euro vs MXN
NYSE
VZ
Verizon Communications
AMEX
XLV
Health Care Select Sector
NYSE
XOM
Exxon Mobil
NYSE
CVX
Chevron
USOTC
BASFY
BASF (QX)
NASDAQ
MSFT
Microsoft
COIN
ETHUSD
Ethereum
CCOM
US30
US 30
CCOM
OILBRENT
Brent Oil
NYSE
MCD
McDonalds
AMEX
SPY
SPDR S&P 500
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados